Skip to Main Content

Revolution Medicines, Inc. Common Stock

RVMD Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
RVMD Income Statement
RVMD Balance Sheet
RVMD Cash Flow

Recent trades of RVMD by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
RVMD Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
RVMD Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
RVMD Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by RVMD's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Methods of treating cancer with an mtor inhibitor Oct. 22, 2024
  • Patent Title: C40-, c28-, and c-32-linked rapamycin analogs as mtor inhibitors Jul. 30, 2024
  • Patent Title: Compounds that participate in cooperative binding and uses thereof May. 21, 2024
  • Patent Title: Ras inhibitors Apr. 09, 2024
  • Patent Title: Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric shp2 inhibitors Aug. 29, 2023
  • Patent Title: Ras inhibitors Aug. 29, 2023
  • Patent Title: Pyridine, pyrazine, and triazine compounds as allosteric shp2 inhibitors Jul. 18, 2023
  • Patent Title: Ras inhibitors Jul. 04, 2023
  • Patent Title: C26-linked rapamycin analogs as mtor inhibitors Jun. 27, 2023
  • Patent Title: Polycyclic compounds as allosteric shp2 inhibitors Jun. 13, 2023
  • Patent Title: Pyridine compounds as allosteric shp2 inhibitors Jun. 13, 2023
  • Patent Title: 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors May. 30, 2023
  • Patent Title: Identifying new therapeutic agents May. 09, 2023
  • Patent Title: Polycyclic compounds as allosteric shp2 inhibitors Apr. 25, 2023
  • Patent Title: Ras inhibitors Mar. 21, 2023
  • Patent Title: Shp2 inhibitor compositions and methods for treating cancer Mar. 07, 2023
  • Patent Title: Ras inhibitors Jan. 31, 2023
  • Patent Title: C40-, c28-, and c-32-linked rapamycin analogs as mtor inhibitors Jun. 21, 2022
  • Patent Title: Solid forms of {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl]-3-[(3s,4s)-4-amino-3-methyl-2-oxa-8- azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl} methanol, a shp2 inhibitor Jan. 11, 2022
  • Patent Title: Bicyclic heteroaryl compounds and uses thereof Nov. 09, 2021
  • Patent Title: Compounds that participate in cooperative binding and uses thereof Jul. 13, 2021
  • Patent Title: Identifying new therapeutic agents Apr. 27, 2021
  • Patent Title: C40-, c28-, and c-32-linked rapamycin analogs as mtor inhibitors Apr. 20, 2021
  • Patent Title: Methods and reagents for analyzing protein-protein interfaces Mar. 16, 2021
  • Patent Title: 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors Mar. 17, 2020
  • Patent Title: Compounds that participate in cooperative binding and uses thereof Jan. 14, 2020
  • Patent Title: Methods and reagents for analyzing protein-protein interfaces Nov. 05, 2019
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of RVMD in WallStreetBets Daily Discussion

RVMD News

Recent insights relating to RVMD

CNBC Recommendations

Recent picks made for RVMD stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in RVMD

RVMD Top Shareholders
Shareholder
Shares Held
RVMD Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

RVMD Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view RVMD Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top